Advertisement

Topics

Zymeworks Reports 2017 Year-End Financial Results

16:05 EDT 14 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today reported financial results for the year ended December 31, 2017. “2017 was marked by a number ...

Other Sources for this Article

Zymeworks Inc.
Investor Inquiries:
Ryan Dercho, Ph.D.
(604) 678-1388
ir@zymeworks.com
or
Media Inquiries:
Angela Bitting
(925) 202-6211
a.bitting@comcast.net

NEXT ARTICLE

More From BioPortfolio on "Zymeworks Reports 2017 Year-End Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...